Search Results

Filter
  • 1-10 of  576 results for ""Intravitreal Injections""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Uveitis Following Intravitreal Injections of Faricimab: A Case Report.

  • Authors : Palmieri F; Western Eye Hospital, Imperial College Healthcare NHS Trust, London, UK.; Younis S

Subjects: Intravitreal Injections* ; Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/adverse effects ; Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/administration & dosage

  • Source: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2024 Oct; Vol. 32 (8), pp. 1873-1877. Date of Electronic Publication: 2023 Dec 22.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Intraocular drugs: pharmacokinetic strategies and the influence on efficacy and durability.

  • Authors : Stewart MW; Knights Templar Foundation, Inc. Professor of Ophthalmology Research Mayo Clinic Alix School of Medicine.

Subjects: Intravitreal Injections* ; Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/administration & dosage ; Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/pharmacokinetics

  • Source: Expert opinion on drug metabolism & toxicology [Expert Opin Drug Metab Toxicol] 2024 Oct; Vol. 20 (10), pp. 977-987. Date of Electronic Publication: 2024 Sep 11.Publisher: Informa Healthcare Country of Publication: England NLM ID: 101228422 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Trends in Anti-Vascular Endothelial Growth Factor Original Medicare Part B Claims in the United States, 2014-2019.

  • Authors : Desai S; University of Connecticut School of Medicine, Farmington, Connecticut, USA.; Sekimitsu S

Subjects: Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/economics ; Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/therapeutic use ; Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/administration & dosage

  • Source: Ophthalmic epidemiology [Ophthalmic Epidemiol] 2024 Oct; Vol. 31 (5), pp. 468-477. Date of Electronic Publication: 2024 Feb 05.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9435674 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

The effect of intravitreal anti-VEGF injections on choroidal vascular index in patients with diabetic macular edema.

  • Authors : Toprak A; Kırıkhan State Hospital, Kırıkhan, Hatay, Turkey.; Koc H

Subjects: Macular Edema*/Macular Edema*/Macular Edema*/drug therapy ; Intravitreal Injections* ; Bevacizumab*/Bevacizumab*/Bevacizumab*/administration & dosage

  • Source: Cutaneous and ocular toxicology [Cutan Ocul Toxicol] 2024 Sep; Vol. 43 (3), pp. 204-210. Date of Electronic Publication: 2024 Jul 19.Publisher: Informa Healthcare Country of Publication: England NLM ID: 101266892 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Acute Sterile Endophthalmitis Following Intravitreal Rituximab Injection in Primary Vitreoretinal Lymphoma: Case Series.

  • Authors : Guneri Beser B; The Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.; Demirci H

Subjects: Intravitreal Injections* ; Endophthalmitis*/Endophthalmitis*/Endophthalmitis*/diagnosis ; Endophthalmitis*/Endophthalmitis*/Endophthalmitis*/etiology

  • Source: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2024 Aug; Vol. 32 (6), pp. 863-868. Date of Electronic Publication: 2023 Mar 23.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Combination Therapy with Anti-VEGF and Intravitreal Dexamethasone Implant for Macular Edema Secondary to Retinal Vein Occlusion.

  • Authors : Cai X; Department of Ophthalmology, Sanmenxia Eye Hospital/Sanmenxia Central Hospital Affiliated to Henan University of Science and Technology, Sanmenxia, China.; Henan International Joint Laboratory of Outflow Engineering, Sanmenxia Central Hospital, School of Medicine, Henan University of Science and Technology, Sanmenxia, China.

Subjects: Retinal Vein Occlusion*/Retinal Vein Occlusion*/Retinal Vein Occlusion*/complications ; Retinal Vein Occlusion*/Retinal Vein Occlusion*/Retinal Vein Occlusion*/drug therapy ; Retinal Vein Occlusion*/Retinal Vein Occlusion*/Retinal Vein Occlusion*/diagnosis

  • Source: Current eye research [Curr Eye Res] 2024 Aug; Vol. 49 (8), pp. 872-878. Date of Electronic Publication: 2024 Apr 19.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8104312 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Intravitreal Clindamycin as an Adjuvant Therapy in Congenital Toxoplasma Retinochoroiditis in a Neonate - A Case Report.

  • Authors : Upadhyaya A; Anant Bajaj Retina Institute, LV Prasad Eye Institute, Hyderabad, India.; Jalali S

Subjects: Clindamycin*/Clindamycin*/Clindamycin*/therapeutic use ; Intravitreal Injections* ; Toxoplasmosis, Ocular*/Toxoplasmosis, Ocular*/Toxoplasmosis, Ocular*/drug therapy

  • Source: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2024 Aug; Vol. 32 (6), pp. 1101-1104. Date of Electronic Publication: 2023 Feb 09.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Intravitreal Anti-Vascular Endothelial Growth Factor and Moxifloxacin for Treatment of Tubercular Choroidal Granuloma and Sub retinal Abscess.

Subjects: Moxifloxacin*/Moxifloxacin*/Moxifloxacin*/therapeutic use ; Intravitreal Injections* ; Vascular Endothelial Growth Factor A*/Vascular Endothelial Growth Factor A*/Vascular Endothelial Growth Factor A*/antagonists & inhibitors

  • Source: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2024 Aug; Vol. 32 (6), pp. 1086-1090. Date of Electronic Publication: 2023 Jan 13.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

One-Year Functional and Morphological Prognosis After Intravitreal Injection Treatments According to Different Morphological Patterns of Diabetic Macular Edema in Real-Life: MARMASIA Study Group Report No.13.

  • Authors : Limon DU; Ümraniye Education and Research Hospital, Department of Ophthalmology, University of Health Sciences, Istanbul, Turkey.; Kaplan FB

Subjects: Intravitreal Injections* ; Macular Edema*/Macular Edema*/Macular Edema*/drug therapy ; Macular Edema*/Macular Edema*/Macular Edema*/diagnosis

  • Source: Seminars in ophthalmology [Semin Ophthalmol] 2024 Aug; Vol. 39 (6), pp. 460-467. Date of Electronic Publication: 2024 Mar 05.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8610759 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Toxoplasma Retinochoroiditis Following Intravitreal Dexamethasone Implant Injection for Diabetic Macular Edema: A Rare Complication.

  • Authors : Ambiya V; Department of Ophthalmology, Armed Forces Medical College, Pune, India.; Shankar S

Subjects: Macular Edema*/Macular Edema*/Macular Edema*/drug therapy ; Macular Edema*/Macular Edema*/Macular Edema*/etiology ; Macular Edema*/Macular Edema*/Macular Edema*/diagnosis

  • Source: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2024 Aug; Vol. 32 (6), pp. 1121-1123. Date of Electronic Publication: 2023 Apr 18.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited

Record details

×
  • 1-10 of  576 results for ""Intravitreal Injections""